Net revenues rose 1.6% to $11.54 billion and reported net earnings increased 29.7% to $4.48 billion, driven by higher pricing and lower impairment charges. Smokeable products outperformed with higher OCI, while oral tobacco faced volume and share declines amid rapid nicotine pouch growth. Litigatio…
Net revenues rose 1.6% to $11.54 billion and reported net earnings increased 29.7% to $4.48 billion, driven by higher pricing and lower impairment charges. Smokeable products outperformed with higher OCI, while oral tobacco faced volume and share declines amid rapid nicotine pouch growth. Litigation, regulatory, and macroeconomic risks remain significant.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
